Loading...

#Eyenuk #EyeArt #AIEyeScreening

Eyenuk EyeArt real world use in Germany: An interview with Prof. Dr. Med. Thomas Haak

205 views

Loading...

Loading...

Transcript

The interactive transcript could not be loaded.

Loading...

Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on May 16, 2019

Prof. Dr. Med. Thomas Haak, Head Physician of Diabetes Center Mergentheim, Founder Member and Board Director of DiabetesDE (German Diabetes Aid) talks about the implementation of EyeArt AI Eye Screening system at their Diabetes Clinic and the impact it is having on their patients.

Access full article here: https://www.eyenuk.com/en/articles/bl...

Visit https://www.eyenuk.com for more information about EyeArt® AI Eye Screening System.

#Eyenuk #EyeArt #AIEyeScreening #DiabeticRetinopathy

EyeArt has been cleared for sales as a Class IIa medical device by EU and as a Class 2 medical device by Health Canada. In the United States, it is limited by federal law to investigational use only.

Comments are disabled for this video.
When autoplay is enabled, a suggested video will automatically play next.

Up next


to add this to Watch Later

Add to

Loading playlists...